Brukinsa: Expiry of patents in US/EU/China/Japan related to composition-of-matter in 2034 (BeOne Medicines) - Mar 24, 2026 - Annual Report 2025: SPC in France, Germany, Italy, Spain and the UK until 2036; Expiry of patents in US/EU/China/Japan related to crystalline forms in 2037; Expiry of patents in US related to method of treatment in 2039 and 2043; Expiry of patents in US related to combination use in 2039 and EU/China in 2037; Expiry of patents in US related to formulation in 2040
Patent • Chronic Lymphocytic Leukemia • Follicular Lymphoma • Hematological Malignancies • Lymphoma • Lymphoplasmacytic Lymphoma • Mantle Cell Lymphoma • Marginal Zone Lymphoma • Non-Hodgkin's Lymphoma • Oncology • Small Lymphocytic Lymphoma • Solid Tumor • Waldenstrom Macroglobulinemia
|